# Product Design Clinical Performance Study of sc2Wear Furosemide Combination Product

> **NCT02804282** · PHASE3 · COMPLETED · sponsor: **scPharmaceuticals, Inc.** · enrollment: 74 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **COMBINATION_PRODUCT:** sc2Wear Furosemide

## Key facts

- **NCT ID:** NCT02804282
- **Lead sponsor:** scPharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07
- **Primary completion:** 2016-11
- **Final completion:** 2016-11
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2018-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02804282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02804282, "Product Design Clinical Performance Study of sc2Wear Furosemide Combination Product". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02804282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
